台股 » 個股 » 共信-KY » 籌碼相關 » 券商分點績效 » 券商分點個股進出

共信-KY

(6617)
  • 股價
    102.0
  • 漲跌
    ▼1.0
  • 漲幅
    -0.97%
  • 成交量
    39
  • 產業
    上櫃 生技醫療類股
  • 40人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
共信-KY (6617)籌碼相關-元大-八德 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-八德 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/1300.001103.00102.00-1134-0.75%
2024/12/121102.5000.00103.0011360.73%
2024/12/0400.001115.00114.00-1155-0.64%
2024/11/1400.001108.50109.00-1251-0.40%
2024/11/131109.0000.00108.5012560.39%
2024/11/081117.5000.00115.0012680.37%
2024/11/0500.001103.00108.00-1275-0.36%
2024/11/041101.0000.00103.5012810.35%
2024/10/2300.001109.00107.00-1297-0.34%
2024/10/221112.0000.00110.5012990.33%
2024/09/2600.001119.50117.50-1358-0.28%
2024/09/2400.001121.50119.50-1365-0.27%
2024/09/192121.0000.00122.5024020.50%
2024/09/1800.002119.00120.50-2428-0.47%
2024/09/101121.001123.00120.0005630.00%
2024/09/052129.0000.00126.0025590.36%
2024/08/271125.5000.00127.5015570.18%
2024/08/231134.001128.00126.0005520.00%
2024/08/2200.001130.00129.00-1543-0.18%
2024/08/192101.7500.00103.0025100.39%
2024/08/14199.50299.7596.50-1499-0.20%
2024/08/121101.5000.00101.5014920.20%
2024/08/0800.002107.25102.50-2487-0.41%
2024/08/071111.5000.00108.5014840.21%
2024/08/062102.7500.00103.5024710.42%
2024/08/051112.5000.00112.0014640.22%
2024/08/011131.002131.00130.50-1456-0.22%
2024/07/191143.0000.00142.0014370.23%
2024/07/1700.003135.50136.00-3418-0.72%
2024/07/156134.5800.00132.5064131.45%
2024/07/121136.002135.00135.00-1410-0.24%
2024/07/092137.0000.00136.0024080.49%
2024/07/080139.0000.00135.0004090.00%
2024/07/0500.003.3139.70139.50-3.3404-0.81%
2024/07/0400.002141.00140.00-2402-0.50%
2024/07/034140.1000.00143.0043931.02%
2024/07/0200.005138.60137.50-5383-1.30%
2024/07/010.1144.0000.00142.500.13780.02%
2024/06/261153.0000.00153.0013570.28%
2024/06/246151.0000.00147.0063291.82%
2024/06/193131.0000.00128.5032141.40%
2024/06/181130.504132.00132.00-3199-1.50%
〈熱門股〉共信-KY旗下PTS進軍寵物市場 跌深反彈周漲逾2成Anue鉅亨-2024/08/24
共信-KY動物抗癌新藥申請台灣藥證 明年H2有望取得藥證Anue鉅亨-2024/07/31
共信-KY 相關文章
共信-KY 相關影音